Can Epstein-Barr virus infection be related to Lyme disease?

EBV and Lyme Disease: Diagnostic Cross-Reactivity, Not Causal Relationship

EBV infection is not causally related to Lyme disease, but significant serologic cross-reactivity between these two infections creates a well-documented diagnostic pitfall that can lead to misdiagnosis in both directions. 1, 2, 3

The Core Problem: False-Positive Serologies

Lyme Disease Can Cause False-Positive EBV Testing

• Early disseminated Lyme disease frequently triggers false-positive serology for primary EBV infection, leading to misdiagnosis as infectious mononucleosis. 1, 4
• Patients with acute Lyme disease presenting with fever, lymphadenopathy, and myalgias may test positive on heterophile antibody tests (monospot), mimicking EBV infectious mononucleosis. 4
• This cross-reactivity can delay appropriate antibiotic treatment for Lyme disease, allowing progression to serious complications including Lyme carditis and Borrelia meningitis. 4

EBV Infection Can Cause False-Positive Lyme Testing

• Acute EBV infection (infectious mononucleosis) generates IgM cross-reactivity in Lyme antibody-capture enzyme immunoassays, producing false-positive Lyme serologies. 5
• Among patients with acute Epstein-Barr virus infections, IgM cross-reactivity with Borrelia burgdorferi testing has been documented in approximately 11% of cases. 5

Clinical Scenarios Where Confusion Occurs

Overlapping Clinical Presentations

• Both infections present with fever, fatigue, lymphadenopathy, and myalgias, making clinical differentiation impossible without proper laboratory interpretation. 2, 3, 4
• The nonspecific nature of early Lyme disease symptoms combined with false-positive EBV testing creates a diagnostic trap, particularly in Lyme-endemic regions. 4

Documented Cases of Dual Positive Serology

• Case reports document patients with confirmed acute Lyme disease who simultaneously tested positive for EBV serology, representing either true co-infection or cross-reactivity. 2, 3
• One case series identified tick-borne myopericarditis with positive Anaplasma, Lyme, and EBV serology, where the EBV positivity was likely a false-positive in the context of acute tick-borne illness. 2

Algorithmic Approach to Avoid Misdiagnosis

When Suspecting Lyme Disease

1. Obtain detailed exposure history: recent outdoor activity in Lyme-endemic areas (Northeast and Upper Midwest US) and tick exposure within the preceding 4-6 weeks. 6
2. Look for erythema migrans (expanding annular lesion >5 cm), which is present in 70-80% of Lyme cases and allows clinical diagnosis without laboratory confirmation. 6
3. If EM is absent, use two-tiered serologic testing (EIA/IFA followed by Western blot) as the gold standard, recognizing that sensitivity is only 30-40% in early infection but 70-100% in disseminated disease. 6
4. Do not rely on monospot or EBV serology alone in patients with potential Lyme exposure, as false-positive EBV testing is well-documented. 1, 4

When Suspecting EBV/Infectious Mononucleosis

1. If monospot is positive but clinical context includes tick exposure or residence in Lyme-endemic areas, obtain Lyme serology before accepting EBV as the diagnosis. 4
2. Recognize that positive heterophile antibody testing does not exclude Lyme disease, particularly if symptoms include facial palsy, cardiac conduction abnormalities, or meningitis—manifestations atypical for uncomplicated mononucleosis. 4

Critical Red Flags Suggesting Lyme Rather Than EBV

• Development of atrioventricular conduction blocks (first-degree or higher) strongly suggests Lyme carditis, not EBV. 4
• Facial nerve palsy (Bell's palsy) or other cranial neuropathies indicate early disseminated Lyme disease. 6
• Aseptic meningitis with lymphocytic pleocytosis in the context of positive EBV serology should prompt Lyme CSF testing. 4, 7

Key Pitfalls to Avoid

Timing of Serologic Testing

• Lyme serology obtained too early (within the first 2-3 weeks of infection) will be negative due to the antibody window period, potentially leading to false reassurance. 6
• If initial Lyme serology is negative but clinical suspicion remains high, repeat testing 2-4 weeks later to capture seroconversion. 6

Over-Reliance on Single Tests

• A positive monospot alone should not close the diagnostic workup in patients with outdoor exposure in endemic areas. 4
• Conversely, positive Lyme serology in patients with acute EBV should be confirmed with two-tiered testing to exclude IgM cross-reactivity. 5

Geographic Context Matters

• In Lyme-endemic regions (Northeast, Upper Midwest), the pre-test probability of Lyme disease is substantially higher, and false-positive EBV testing should be suspected when clinical features are atypical for mononucleosis. 6, 4

When True Co-Infection May Occur

• Rare cases of probable concurrent acute Lyme and EBV infections have been reported, though distinguishing true co-infection from serologic cross-reactivity remains challenging. 3
• In such cases, treat the more immediately dangerous infection (Lyme disease with doxycycline) while monitoring for complications of both. 2, 3